Free shipping on all orders over $ 500

Ponatinib hydrochloride

Cat. No. M9009
Ponatinib hydrochloride Structure
Synonym:

AP24534 HCl

Size Price Availability Quantity
10mg USD 50  USD50 In stock
25mg USD 90  USD90 In stock
50mg USD 140  USD140 In stock
100mg USD 210  USD210 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ponatinib hydrochloride potently inhibits proliferation of Ba/F3 cells expressing native BCR-ABL (IC50 = 0.5 nM). Ponatinib hcl (AP24534) inhibits the in vitro kinase activity of FLT3, KIT, FGFR1, and PDGFRα with IC50 values of 13, 13, 2, and 1 nM, respectively. Ponatinib inhibits phosphorylation of all 4 RTKs in a dose-dependent manner, with IC50 values between 0.3 to 20 nM.

In vivo, in a mouse xenograft model of Ba/F3 cells expressing native Bcr-Abl, AP24534 (2.5 mg/kg and 5 mg/kg) prolongs mice median survival. In the xenograft model of Ba/F3 Bcr-AblT315I, Ponatinib hydrochloride (10 mg/kg–50 mg/kg) significantly suppresses tumor growth. AP24534 (30 mg/kg) decreases the phosphorylated Bcr-Abl and phosphorylated CrkL levels in the tumors.

Chemical Information
Molecular Weight 569.03
Formula C29H28ClF3N6O
CAS Number 1114544-31-8
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Gozgit JM, et al. Mol Cancer Ther. Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models.

[2] Gozgit JM, et al. Mol Cancer Ther. Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies.

[3] OHare T, et al. Cancer Cell. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

Related Src-bcr-Abl Products
Asciminib hydrochloride

Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM.

Osteogenic Growth Peptide (10-14)

Osteogenic Growth Peptide (10-14) (OGP(10-14)), the C-terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP-like activity.

Abl Cytosolic Substrate

Abl Cytosolic Substrate is a substrate for Abelson tyrosine kinase (Abl ).

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH is a high-affinity pentapeptide to bind to the src SH2 domain (IC50≈1 µM).

p60c-src substrate II

p60c-src substrate II is an efficient pentapeptide substrate for the tyrosine kinase pp60c-src.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ponatinib hydrochloride, AP24534 HCl supplier, Src-bcr-Abl, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.